ArticleBMC veterinary research2025
Seroprevalence and associated risk factors of dromedary camel (Camelus dromedaries) Toxoplasma gondii in selected districts of Borana zone, Oromia, Ethiopia (short communication).
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundToxoplasmosis in camels is an important zoonotic infection with considerable economic and public health impacts, particularly in the pastoral regions of Ethiopia.
methodsA cross-sectional study was conducted in selected districts of the Borana zone, Southern Oromia of Ethiopia, to estimate the Toxoplasma gondii seroprevalence infection and associated risk factors in camels. Accordingly, 352 camel blood samples were randomly collected. Then, the sera were separated from the blood and analyzed using a latex agglutination test.
resultsAccording to this study, the seroprevalence of camel T. gondii in the study districts using the latex agglutination test was 7.9%. The current study revealed that the T. gondii seroprevalence was relatively higher in the Miyo (9.1%) district. The males (8.9%), the adult age group (5.8%), and the poor-condition camels (21.0%) had higher seroprevalence. There was a statistically significant association between the body condition and the seroprevalence of camel T. gondii (p = 0.016). However, no statistically significant difference was noted between the seroprevalence of camel T. gondii and the peasant association, districts, age, and sex.
conclusionThis study revealed a significant prevalence of Toxoplasma gondii infection in camels, posing a potential public health risk in the study area. To effectively control the disease and minimize its impact on both animal and human health, it is important to raise public awareness, implement practical biosecurity measures, and conduct further comprehensive studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.